1. Companies

  2. Infinity Pharmaceuticals

Infinity Pharmaceuticals

Infinity Pharmaceuticals

closed
Discovery and development of medicines for the treatment of cancer and related conditions. Learn more
Launch date
Employees
201-500 people
Market cap
$1.6m
Enterprise valuation
($15m) (Public information from Sep 2023)
Cambridge Massachusetts (HQ)
http://infi.com
https://twitter.com/infipharmahttps://www.linkedin.com/company/ipi

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD201720182019202020212022
Revenues6.0m22.0m3.0m2.0m2.0m3.0m
% growth-267 %(86 %)(33 %)-50 %
EBITDA(35.0m)(12.0m)(45.0m)(38.0m)(45.0m)(44.0m)
% EBITDA margin(583 %)(55 %)(1500 %)(1900 %)(2250 %)(1467 %)
Profit(42.0m)(11.0m)(47.0m)(40.0m)(45.0m)(44.0m)
% profit margin(700 %)(50 %)(1567 %)(2000 %)(2250 %)(1467 %)
EV / revenue8.6x0.4x14.8x77.2x85.3x20.2x
EV / EBITDA-1.5x-0.7x-1.0x-4.1x-3.8x-1.4x
R&D budget20.8m19.8m27.1m26.8m31.6m32.4m
R&D % of revenue347 %90 %904 %1338 %1582 %1080 %

Source: Dealroom estimates

    • Edit
DateInvestorsAmountRound
-

N/A

-

$70.0m

Series B

$25.0m

Late VC

$75.0m

Late VC
N/A

N/A

IPO
N/A

$50.0m

Post IPO Debt

$27.5m

Post IPO Equity

$78.5m

Post IPO Equity
N/A

$20.0m

Post IPO Equity
N/A

$92.0m

Post IPO Equity
Total Funding$170m

Related Content

Recent News about Infinity Pharmaceuticals

Edit
More about Infinity Pharmaceuticalsinfo icon
Edit

Infinity Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative cancer therapies. The company primarily targets the immune system to treat advanced melanoma and other malignancies. Operating in the biotechnology sector, Infinity Pharmaceuticals serves patients with severe cancer conditions, collaborating with leading medical institutions and researchers. The company’s business model revolves around the research, development, and commercialization of novel drugs. Revenue is generated through the sale of approved therapies and partnerships with other pharmaceutical companies. Infinity Pharmaceuticals leverages its scientific expertise and strategic collaborations to advance its drug pipeline, aiming to bring life-saving treatments to market.

Keywords: biopharmaceutical, cancer therapies, immune system, advanced melanoma, biotechnology, drug development, commercialization, strategic collaborations, novel drugs, life-saving treatments.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Infinity Pharmaceuticals

Edit
MEI Pharma (Formerly Marshall Edwards)
MEI Pharma (Formerly Marshall Edwards)
ACQUISITION by Infinity Pharmaceuticals Jul 2023